PLUS THERAPEUTICS, INC. — Director's Dealing 2016

Feb 5, 2016

SEC Form 4/A — Form 4/A

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2016-01-28

Reporting Person: Girao Tiago (VP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-28	Common Stock	A	35250	—	Acquired	126250	Direct

Footnotes

F1: Represents shares of Common Stock issued under the Company's 2015 Executive Management Incentive Compensation Plan and vested based upon level of achievement of certain metrics related to clinical trial enrollment and the Company's financial position for the performance period of May 26, 2015 to December 31, 2015. All shares were issued pursuant to the Company's 2014 Equity Incentive Plan.

F2: Includes 3,000 shares of Common Stock purchased through the 2011 Employee Stock Purchase Plan on November 30, 2015.